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Abstract A new mutation in human F1F0 ATPase6, T9176G,
which changes Leu 217 to an Arg, has been described in two
siblings with Leigh syndrome [Carrozzo et al. (2000) Neurology,
in press]. This mutation was modeled in Escherichia coli by
changing Leu 259 (the equivalent residue) to Arg and the
properties of the altered ECF1F0 were compared to those of
previously characterized ATPase6 mutants also modeled in the
E. coli enzyme. The L259R change produced a fully assembled
ECF1F0 which had no significant ATP hydrolysis, ATP synthesis
or proton pumping functions. This is very different from
previously described human ATPase6 mutations. The presence
of Arg at position 259 in subunit a did not make membranes
permeable to protons. We conclude that the mutation inhibits
functioning by blocking the rotary motor action of the
enzyme. ß 2000 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
An ATP synthase of the F1F0 type is present in the bacte-
rial plasma membrane, chloroplast thylakoid membrane and
mitochondrial cristal membrane and this enzyme is responsi-
ble for most of the ATP production in cells [1]. Not surpris-
ingly, mutants that a¡ect the functioning of the ATP synthase
in humans are pathogenic. In mammals, including humans,
two subunits of the enzyme complex, subunits 6 and A6L,
are encoded on mitochondrial DNA (mtDNA) [2]. A number
of pathogenic mutants in subunit 6 have been reported [3^8].
Here we have examined the functional consequences of a
newly reported subunit 6 mutation, T9176G [9], by modeling
this change of Arg for Leu in the Escherichia coli ATP syn-
thase. The position of the mutation in human subunit 6 is
residue 217, which is equivalent to position 259 in the E. coli
a subunit. For reference we have compared the properties of
the mutant aL259R with those of three other well described
subunit 6 mutations. When modeled in E. coli these are L259P
(equivalent nucleotide position T9176C in humans) [10],
L207R (T8993G) [11] and L207P (T8993C) [10,12]. The
T9176G mutation is di¡erent from the others. It is a fully
assembled enzyme with essentially no ATPase activity and a
very low ATP synthesis rate.
2. Materials and methods
2.1. Construction of mutants in the unc operon
Site-directed mutagenesis of a plasmid containing the unc operon
[13] was performed using a two-step PCR method [14]. The ¢rst PCR
reaction involves an upstream sense primer (GTACTGGGTC-
TGCCTGCACT) and one of the 3P antisense mutagenic primers:
L259R-TAGACGATCGTCCGAACCATGAAGA, L259P-TAGAC-
GATCGTCGGAACCATGAAGA, L207R-AGTCGCAAACCGCG-
TGAAACTG. Nucleotides highlighted are mismatches to generate
the desired mutation. These fragments were then used as the 5P prim-
ers in a second PCR reaction together with a downstream antisense
primer (TTTCGCGAGCTGTTGTTCAC). The product of the sec-
ond PCR was digested with DraIII restriction endonuclease and the
resulting 1581 bp fragment containing each mutation was subcloned
into the pRA100 vector [13]. The construction of L207P was described
earlier [10]. Sequence analysis of the puri¢ed plasmids was performed
in order to con¢rm the presence of the mutated nucleotide. The plas-
mid containing the mutants was used to transform RA1 cells, which
lack the unc operon [15]. Cells were harvested and an inner membrane
fraction was isolated as described by Foster and Fillingame [16].
2.2. H+ pumping measurements
100 Wg of inner membranes were used to measure the £ux of the
protons across the membrane [17]. Changes in pH were monitored by
9-amino-6-chloro-2-methoxyacridine (ACMA) £uorescence quenching
with an SLM 8000 £uorimeter at 480 nm using an excitation wave-
length of 410 nm.
2.3. ATPase assay
20 Wg of the inner membrane was used to measure the ATP hydro-
lysis ability of E. coli F1F0 ATPase (ECF1F0), following the method
of Lotscher et al. [18]. Dicyclohexylcarbodiimide (DCCD) sensitivity
was performed in parallel. Inhibition by 40 WM DCCD was moni-
tored for 1 h at room temperature. To assay the ATPase activity of
the F1 part freed of the in£uence of F0, the assay medium was sup-
plemented with 0.5% N,N-dimethyldodecylamine-N-oxide (LDAO).
The absorbance change at 340 nm was followed in a Beckman DU7
spectrophotometer.
2.4. ATP synthesis
50 Wl of inner membrane, containing 50 Wg of protein, was resus-
pended in 450 Wl of 25 mM Tris^HCl pH 7.5, 5 mM MgCl2, 10%
glycerol, 10 mM ADP, 10 mM K2HPO4. 2 mM NADH was used to
start the synthesis of ATP; after 3 min of incubation at 37‡C the
reaction was stopped with 0.1 M trichloroacetic acid. The amount
of ATP in the sample was determined using an ATP bioluminescent
assay kit (Sigma chemical company). The light emitted, when ¢re£y
luciferase catalyzed the oxidation of D-luciferin, is proportional to the
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amount of ATP present in the sample and was followed in a lumin-
ometer (Turner TD-20 Luminometer).
2.5. Other methods
Gel electrophoresis was preformed according to Laemmli [19] in a
15% gel. For Western blotting, gels were transferred to PVDF mem-
branes (0.45 WM pore size, Millipore). Reactive bands were detected
with ECL+ kit (Amersham Pharmacia Biotech) or with alkaline phos-
phatase methods (Bio-Rad). Anti-K, anti-Q and anti-b monoclonal
antibody were prepared and characterized in this laboratory, anti-a
polyclonal antibodies were a kind gift from Dr. S. Vik. Protein con-
centrations were determined with the BCA protein assay (Pierce
chemical Co.).
3. Results
The rates of ATP synthesis, ATP hydrolysis and the DCCD
sensitivity of the ATPase activities of the L259R mutant have
been compared with the same measurements for L259P,
L207R and L207P in Fig. 1A. It can be seen that the ATPase
activity of the L259R mutant was very low and essentially the
same as for an unc3 strain with no F1F0 assembled. In com-
parison, the L259P and the two di¡erent mutants at position
207 each had ATPase activities of around 50% of the wild
type. Note that the L259P and L207P mutants retain
DCCD sensitivity, although at a lower level than the wild
type, as reported previously [10], while the L207R mutant
shows essentially no sensitivity to DCCD, as reported previ-
ously [11]. Fig. 1A also shows the activities of the four ATP-
ase mutants after addition of LDAO to the membranes. This
detergent disrupts the interaction between the F1 and F0 parts
without releasing the F1 from membranes [20]. The ATPase
activity obtained in LDAO is therefore a measurement of the
total amount of assembled F1 on the membrane. As indicated
in Fig. 1A, the amount of ECF1 assembled in the L259R
mutant was the same as in wild type (and in L259P and
L207P mutants). Only in the mutant L207R was there signi¢-
cantly less ATPase assembled, and even then the e¡ect was
small. The ATP synthesis activity of the L259R mutant was
very low, as was that of the L207R mutation. Both the L259P
and L207P mutants retained some ATP synthesis function, i.e.
60% and 25%, respectively. As expected from the above re-
sults, the L259R mutant showed negligible ATP driven proton
pumping activity when measured by the ACMA quenching
assay (Fig. 2). However, NADH driven proton pumping
was essentially normal, indicating that the mutation in subunit
a has not made the membrane intrinsically permeable to pro-
tons.
Fig. 1. ATPase and ATP synthase activities of wild type, null,
L259R, L259P, L207R and L207P mutants. (A) ATPase activities of
membranes were measured as described under Section 2. 20 Wg of
membranes were used in each case to measure activity (gray),
DCCD sensitivity (white) and LDAO activation (black) of ATPase
activity. Error bars indicate the maximum variation between four
measurements. (B) ATP synthase activities of 50 Wg samples of
membranes were measured as described under Section 2. An average
of three determinations is shown.
Fig. 2. NADH- and ATP-dependent ACMA quenching of mem-
branes containing wild type (solid), L207R (dotted), and L259R
(dashed) F1F0 ATP synthase. Membranes at 100 Wg/ml in HMK
bu¡er (10 mM HEPES pH 7.5, 5 mM MgCl2, 100 mM KCl) were
incubated with 1 WM ACMA, and 3.6 WM valinomycin. Assays
were then supplemented with 2 mM NADH, 2 mM KCN, 2 mM
ATP and 3.6 WM nigericin at the time points shown. Proton pump-
ing in response to NADH demonstrates the integrity of the inner
membrane vesicles, then this activity is eliminated by KCN. Proton
pumping by F1F0 can then be demonstrated by addition of ATP at
the time point shown.
Fig. 3. Western blot of washed inner membranes probed with a
polyclonal antibody against subunit a and monoclonal antibodies
against subunits Q, b, and K. 20 Wg of wild type, null, L259R,
L259P, L207R, and L207P were loaded per lane.
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Antibodies are available to all of the subunits of the
ECF1F0. Western blotting with this set showed that the level
of the enzyme in the L259R mutant (per mg of membrane
protein) is similar to that of wild type, although this method
of estimation is not as quantitative as obtained by the LDAO-
stimulated ATPase activity measurement. More importantly,
the blots in Fig. 3 show that the mutant L259R had a full
complement of all subunits, as is the case for the L259P mu-
tant. In the L207R mutant, assembly of the subunit a into the
complex was poor while the levels of subunits b, K and Q were
near normal.
4. Discussion
Mutations of mtDNA in the gene encoding ATPase6 are
being reported with increasing frequency. The pathogenicity
of these mutations depends on the amino acid altered, the
percentage of enzyme molecules showing the mutation which
is related to the heteroplasmy, and the tissue distribution of
mutated DNA molecules [3]. Not surprisingly genotype^phe-
notype relationships are di⁄cult to understand in such pa-
tients. The overall structure and functioning of the ATP syn-
thase is well conserved in all forms of life. Subunit a of the
ECF1F0 is 23% identical and has 44% homology with subunit
6 of the human enzyme. Most of the pathogenic mutations in
humans are in amino acids conserved between the two subunit
forms. This is the case for the recently described human mu-
tant T9176G [9]. A recent study of a family harboring this
mutation at di¡erent levels of heteroplasmy suggests that this
particular mutation is as severe, or more severe, than other
mutations described so far in subunit 6 [9]. The highly dele-
terious e¡ect of substituting an Arg for a Leu at position 217
in humans is con¢rmed here by replacing the equivalent Leu
(at position 259) with Arg in the E. coli enzyme. The mutant
aL259R showed essentially no ATPase activity, which is dif-
ferent from all other subunit 6 mutations modeled in E. coli.
ATP synthesis was also dramatically reduced and no measur-
able ATP driven proton pumping was obtained.
Most importantly the low levels of ATP hydrolysis and
ATP synthesis do not result from a failure of the enzyme
complex to assemble or from instability of the enzyme in
the L259R mutant membranes. There are normal amounts
of F1 present which functions to give LDAO-stimulated ATP-
ase activities equivalent to wild type. Moreover the levels of
subunits including subunit a are normal. The L259R mutant
clearly assembles much better than the L207R mutant when
all experiments are run in parallel with both mutants.
The assembly of the F1F0 in human cells cannot be deter-
mined at present. We have monoclonal antibodies to subunits
K, L, d and the inhibitor protein. Western blotting of ¢bro-
blast mitochondria from the patient with the T9176C muta-
tion at close to homoplasmy with these antibodies shows nor-
mal levels of the four polypeptides (results not shown). This is
not the case for Rhoo cells where ATPase6 is not synthesized
and subunit d is diminished in amount [21]. Unfortunately an
antibody against subunit 6 is not yet available with which to
assess incorporation of this subunit.
In summary, the pathological mutation T9176G when mod-
eled in ECF1F0 by replacing Leu 259 with an Arg produces a
novel enzyme that has all of the subunits present, with an F1
that is highly active when the interaction with F0 is disrupted
but yet shows no signi¢cant functioning in membranes. The
mutation does not lead to uncoupling and is in every way
equivalent to reacting F1F0 with the inhibitor DCCD. In re-
cent models of functioning of the ATP synthase this would
suggest that an Arg at position 259 blocks the rotation of the
c subunit ring [22,23].
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